Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
March 12, 2026 21:03 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
Celebrating Women’s Role in the Evolving Financial Sector
PORT VILA, Vanuatu, March 10, 2026 /PRNewswire/ -- The global financial market…
Navi Finserv convenes close to 200 financial sector leaders at the 3rd Navi Lenders Summit 2026
Strengthens partnerships with close to ₹16,000 crore raised since April 2025 across…
CalAmp To Appoint Maurizio Iperti as CEO Following Another Year of Strong Financial and Operational Performance
Generated $41 Million of Free Cash Flow in 2025 Entered 2026 with…
Oculis Publishes 2025 Consolidated Financial Statements
ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Following the Company‘s press…
Huawei Elevates Financial AI Solutions to Power Digital and Intelligent Transformation in Global Finance
BARCELONA, Spain, March 4, 2026 /PRNewswire/ -- During MWC Barcelona 2026, Huawei hosted…
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Presented positive updated data from the ALLOHA™ Phase 1 heme trial at…
Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026
Company to Host Conference Call at 8:30am ET March 04, 2026 07:00…
Orion Group Financial Statement documents 2025 and Remuneration Report published
ORION CORPORATION STOCK EXCHANGE RELEASE – ANNUAL FINANCIAL REPORT 27 FEBRUARY 2026…
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated…
